This topic contains a solution. Click here to go to the answer

Author Question: ICD-10-CM Chapter 7, Diseases of the Eye and Adnexa is a new chapter and did NOTexist in ICD-9-CM. ... (Read 98 times)

Sportsfan2111

  • Hero Member
  • *****
  • Posts: 585
ICD-10-CM Chapter 7, Diseases of the Eye and Adnexa is a new chapter and did NOTexist in ICD-9-CM.
 
  Indicate whether this statement is true or false.

Question 2

Which of the following is NOT a key criterion for abstracting ophthalmic complications of diabetes?
 
  a. Is the diabetes type 1 or type 2?
  b. Is the condition retinopathy?
  c. If it is type 2, does the patient use insulin?
  d. What is the laterality?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Tonny

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

TRUE

Answer to Question 2

Answer: d




Sportsfan2111

  • Member
  • Posts: 585
Reply 2 on: Jun 27, 2018
YES! Correct, THANKS for helping me on my review


upturnedfurball

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Excellent

 

Did you know?

Historic treatments for rheumatoid arthritis have included gold salts, acupuncture, a diet consisting of apples or rhubarb, nutmeg, nettles, bee venom, bracelets made of copper, prayer, rest, tooth extractions, fasting, honey, vitamins, insulin, snow collected on Christmas, magnets, and electric convulsion therapy.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

For a complete list of videos, visit our video library